To determine the optimal tolerated regimen (OTR) of pazopanib and ixabepilone when used in combination by evaluation of toxicity and tolerability At first cycle (Week 3) [clinicaltrials_resource:0f377e8024f02336600a5baa3504652d]
Patient receives assigned dose level:
Dose Level 1 = 400 milligrams (mg) of pazopanib and ixabepilone 25 mg/m2. Dose Level 2 = 400 milligrams (mg) of pazopanib and ixabepilone 32 mg/m2. Dose Level 3 = 600 milligrams (mg) of pazopanib and ixabepilone 32 mg/m2. Dose Level 4 = 800 milligrams (mg) of pazopanib and ixabepilone 32 mg/m2.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To determine the optimal tolerated regimen (OTR) of pazopanib and ixabepilone when used in combination by evaluation of toxicity and tolerability At first cycle (Week 3) [clinicaltrials_resource:0f377e8024f02336600a5baa3504652d]
Patient receives assigned dose level:
Dose Level 1 = 400 milligrams (mg) of pazopanib and ixabepilone 25 mg/m2. Dose Level 2 = 400 milligrams (mg) of pazopanib and ixabepilone 32 mg/m2. Dose Level 3 = 600 milligrams (mg) of pazopanib and ixabepilone 32 mg/m2. Dose Level 4 = 800 milligrams (mg) of pazopanib and ixabepilone 32 mg/m2.
Bio2RDF identifier
0f377e8024f02336600a5baa3504652d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0f377e8024f02336600a5baa3504652d
measure [clinicaltrials_vocabulary:measure]
To determine the optimal toler ...... n of toxicity and tolerability
time frame [clinicaltrials_vocabulary:time-frame]
At first cycle (Week 3)
description
Patient receives assigned dose ...... anib and ixabepilone 32 mg/m2.
identifier
clinicaltrials_resource:0f377e8024f02336600a5baa3504652d
title
To determine the optimal toler ...... bility At first cycle (Week 3)
@en
type
label
To determine the optimal toler ...... 77e8024f02336600a5baa3504652d]
@en